McKinsey & Company Skip main navigation

Insights & Publications

Pharmaceuticals & Medical Products

HealthCareSupplyChain_1536x1152_Thumbnail
article

Strengthening health care’s supply chain: A five-step plan

September 2013—Dramatically changing the sector’s inefficient supply chain may eliminate the dangers posed by counterfeiting and medication errors.more

  • includes:
    •  

Editor's choice

hobi13_frth_Thumbnail
article

How big data can revolutionize pharmaceutical R&D

April 2013—Pharmaceutical R&D suffers from declining success rates and a stagnant pipeline. Big data and the analytics that go with it could be a key element of the cure.more

  • includes:
    •  
restoring value to pharmaceutical r&d
article

Restoring value to biopharmaceutical R&D

August 2012—After years of seeing value destroyed by R&D excesses, biopharmaceutical companies can gain healthier returns—but only if they recognize several new imperatives.more

awak11_frth_Thumbnail
article

A wake-up call for Big Pharma

December 2011—Lower profit margins suggest a need for new business models.more

inch12_frth_Thumbnail
interview

Innovating in China’s pharma market: An interview with AstraZeneca’s head of R&D in Asia and emerging markets

February 2012—The country may well foster new models of innovation, but success will require a long-term commitment and talent development.more

cabr12_frth_Thumbnail
article

Capturing the Brazilian pharma opportunity

April 2012—Global pharma companies are missing a chance to serve Brazil’s increasingly prosperous and growing middle class.more

heca12_frth_Thumbnail
article

Health care in China: Entering ‘uncharted waters’

November 2012—Multinationals are flocking to take advantage of the opportunities, but long-term success is by no means assured.more

phma12_frth_Thumbnail
article

Pharma manufacturing for a new era

August 2012—The sector can restore lost value by focusing intently on manufacturing innovation.more

newa10_frth_Thumbnail
article

The next wave of change for US health care payments

May 2010—The development of an automated payment network would reduce bad debt, cut administrative costs, and save billions of dollars.more

emma10_frth_Thumbnail
article

The emerging market in health care innovation

May 2010—Innovators—some from developing nations—have found ways to deliver care effectively at significantly lower cost while increasing access and quality.more

mipe10_frth_Thumbnail
article

The microeconomics of personalized medicine

February 2010—Personalized medicine promises to increase the quality of clinical care and, in some cases, to decrease health care costs. The biggest hurdles are economic, not scientific.more

rdem10_frth_Thumbnail
article

R&D in emerging markets: A new approach for a new era

February 2010—Gone is the time when R&D in developed markets could meet the pharmaceutical needs of emerging ones. A local presence is required.more

enco10_frth_Thumbnail
article

Engaging consumers to manage health care demand

January 2010—Payors can help improve consumers’ health and reduce costs by providing information, choice, and incentives that encourage healthier lifestyles and value-conscious consumption of health care. more

About this content

The material on this page draws on the research and experience of McKinsey consultants and other sources. To learn more about our expertise, please visit the Healthcare Systems & Services Practice, Operations Practice, Pharmaceuticals & Medical Products Practice.